Why Moderna Stock Is Surging Today
Shares of Moderna (NASDAQ: MRNA) are surging today, up 12.7% as of 10:07 a.m. EDT. The nice gain came after the biotech announced on Tuesday the publication of results from a phase 1 study of COVID-19 vaccine candidate mRNA-1273 in The New England Journal of Medicine. The clinical study was led by the National Institute of Allergy and Infectious Diseases (NIAID).
Those results revealed that neutralizing antibodies (which can prevent infection by the novel coronavirus that causes COVID-19) were found in all 45 participants involved in the phase 1 study. Moderna's experimental vaccine also appeared to be generally safe and well tolerated.
Image source: Getty Images.
Source Fool.com
